Comparison of a novel Aspergillus lateral-flow device and the Platelia® galactomannan assay for the diagnosis of invasive aspergillosis following haematopoietic stem cell transplantation

Evaluation of Real-Time PCR, Galactomannan Enzyme-Linked Immunosorbent Assay (ELISA), and a Novel Lateral-Flow Device for Diagnosis of Invasive Aspergillosis

(2013) P. L. White et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies

(2012) Mitsutoshi Kurosawa et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Interlaboratory and Interstudy Reproducibility of a Novel Lateral-Flow Device and Influence of Antifungal Therapy on Detection of Invasive Pulmonary Aspergillosis

(2012) N. P. Wiederhold et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients

(2012) Martin Hoenigl et al.   JOURNAL OF INFECTION

Aspergillosis in the ‘Nonimmunocompromised’ Host

(2011) David A. Stevens et al.   IMMUNOLOGICAL INVESTIGATIONS

Comparison of Lateral Flow Technology and Galactomannan and (1->3)- -D-Glucan Assays for Detection of Invasive Pulmonary Aspergillosis

(2009) N. P. Wiederhold et al.   Clinical and Vaccine Immunology

Development of an Immunochromatographic Lateral-Flow Device for Rapid Serodiagnosis of Invasive Aspergillosis

(2008) C. R. Thornton   Clinical and Vaccine Immunology

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES